Detalhe da pesquisa
1.
Chromatin-Based Classification of Genetically Heterogeneous AMLs into Two Distinct Subtypes with Diverse Stemness Phenotypes.
Cell Rep;
26(4): 1059-1069.e6, 2019 01 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30673601
2.
Multi-omics profiling reveals a distinctive epigenome signature for high-risk acute promyelocytic leukemia.
Oncotarget;
9(39): 25647-25660, 2018 May 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29876014
3.
Combined HAT/EZH2 modulation leads to cancer-selective cell death.
Oncotarget;
9(39): 25630-25646, 2018 May 22.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29876013
4.
HDAC2 deregulation in tumorigenesis is causally connected to repression of immune modulation and defense escape.
Oncotarget;
6(2): 886-901, 2015 Jan 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25473896
5.
Anti-mullerian hormone is expressed by endometriosis tissues and induces cell cycle arrest and apoptosis in endometriosis cells.
J Exp Clin Cancer Res;
33: 46, 2014 May 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24886254
6.
Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392.
Cancer Res;
74(8): 2328-39, 2014 Apr 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24566867
7.
MePR: a novel human mesenchymal progenitor model with characteristics of pluripotency.
Stem Cells Dev;
22(17): 2368-83, 2013 Sep 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23597129
8.
The class I-specific HDAC inhibitor MS-275 modulates the differentiation potential of mouse embryonic stem cells.
Biol Open;
2(10): 1070-7, 2013.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24167717